Japan's medical representative system: Pei Zhang on duty is only the appearance of the fundamental reform of the system is the focus!

Last week, the Japan Medical Representative (MR) Identification Center published the MR Identification Framework, which stipulates that from April next year, Japan's pharmaceutical representatives will be obliged to wear an MR badge in addition to a certificate of identification at work.
the news that "Japanese medical representatives will be on duty" was swiped at home.
, wearing a badge in Japan is far more symbolic than it really is.
is somewhat more like a tradition in Japanese society, where professions such as lawyers, judges and prosecutors require badges to be worn "in the performance of their duties", which is probably no stranger to Japanese drama.
But in real life, because badges don't have any identification and don't have any proof of validity, and because of convenience and cost (a silver lawyer badge is priced at about 100,000 yen), it's also common in Japan not to wear badges in the performance of your duties.
the purpose of wearing an MR badge, the Platform states that "the purpose is for medical representatives to carry out activities for patients with high aspirations and a sense of mission."
", it's more of an incentive.
the details of the "Chapter on duty" is precisely the impact of the Outline on Japan's pharmaceutical representative system.
August this year, the Japan MR Identification Center, which is the core of the Japanese pharmaceutical representative identification system, held a meeting to clarify that the "MR identification outline" will be formulated as part of the "fundamental reform" of the certification system for Japanese pharmaceutical representatives.
and the official publication of the Platform marked the first step in a "fundamental reform" affecting Japan's pharmaceutical representative system.
is the system for Japanese medicine representatives? What kind of development has been experienced? Why do we have to carry out fundamental reforms now? As the filing system for our medical representatives is about to be officially launched, let's look at our neighbors and see what happens. The medical representative in the dawn Chinese context of 01 centenary years ago, the official name in Japanese is "medical emetic person in charge" (head of medical information), commonly known as MR, or English Medical Representative.
, MR is usually composed of specialized personnel as part of the pharmaceutical company's business unit or from a talent dispatching company to the pharmaceutical company.
MR dates back to the Meiji era a hundred years ago.
the meiji government gradually relaxed its medical policy, and by the first decade of the 20th century, imports of Western drugs through foreign shops in Yokohama, Kobe and other places were increasing, and the Japanese drug market was largely shifting from Chinese medicine to Western medicine.
, on the other hand, has spurred domestic pharmaceutical companies to try to import or even manufacture their own Western drugs.
In particular, three of them have been the most active in the production of Chinese prescription drugs (Takeda, Yannoyi, Tianbian), who not only stopped importing and processing Western drugs, but also began to guide their pharmacists to sell and sell.
japanese medicine representative's prototype is also in the manufacture, production, sale of Western drugs in the soil of one-stop brewing.
Meiji 45 (1912), a Swiss company that became a multinational pharmaceutical giant, pushed pharmaceutical representatives to the fore in Japan by chance.
that Roche had just landed in Japan in 1911 and was eager to open up the situation for its products.
, who was in charge of the Japanese market at the time, thought hard and decided to find a "medically knowledgeable, fluent German"-speaking Japanese to help him.
who was eventually chosen by him after several twists and turns was Japanese pharmacist Eriyo Miyagi.
, after some guidance and training, in 1912, this wonderful combination of ocean day frequently appeared in Medical Institutions large and small in Japan to start their "medical representative" journey.
Ebeling told the Palace at first that they would not take the form of sales, but would follow the "propaganda approachパ of modernization that prevailed in Europe at the time, and called himself a "propagandaist" (プパパ, a Japanese-language propaganda from English.
they held lectures in various places to bring together doctors from universities and doctors' associations.
the meeting, they used posters for product displays, drug samples and related literature, and the two answered questions from the participants one by one and held a banquet after the meeting to communicate privately with the doctor.
this was unprecedented in Japan at the time.
the duo, wearing a dome hat, a black coat and two rickshaws, hurried away, only to explain and promote without sales at the time.
japanese domestic pharmaceutical companies have begun to follow suit, and this "no sales" approach is beginning to spread in Japan.
, which is considered the origin of Japan's medical representative system, was also named the first Japanese medicine representative.
in 2012 at the 100th anniversary of the birth of Japanese pharmaceutical representatives, this history called the Japanese medicine representative system "dawn period", including the second Miya Changping, nine companies, 10 pharmaceutical representatives also as the dawn of the forerunner of the official confirmation.
Although the name of the propagandist and the methods there are long changed in the years that followed, "the nature of providing doctors with the necessary information for the popularization of their own medicines" is still inherited by today's Japanese medical representatives.
02 The dawn of Japan's medical representative system is finally dawn, and it is Japan after World War II that really created today's Japanese medical representative system.
the 1960s, Japan enacted a pharmaceutical law and established the Japan Pharmaceutical Industry Association and the Japan Generic Pharmaceutical Association, with the post-war economic take-off of the Japanese pharmaceutical industry began to develop rapidly.
but due to the inability to rely on, in the fierce market competition in this period of Japanese pharmaceutical representatives gradually evolved into sales staff, "kickbacks, hospitality ... Nothing is taboo" is a representation of Japanese medicine in that era.
to reverse the growing chaos, the government began to try to intervene.
1979, japan's parliament proposed the introduction of MR qualification system, and asked the Japan Pharmaceutical Industry Association to produce the MR Education Program.
1980, the Japan Pharmaceutical Industry Association set up a special committee on education, and formulated the "Medical Intelligence Agent Education and Research Program" was officially launched.
same year, the Japan Federation of Pharmaceutical Groups also established a liaison association for educational and research relations groups.
set of industry guidelines, for all pharmaceutical representatives of Japanese pharmaceutical companies in the education system education and training system was formally established.
1991, the term "propaganda" for nearly 80 years was replaced by MR.
1993, Japan's Ministry of Health and Health held a "Pharmaceutical Conference for the 21st Century", which affirmed the importance of the pharmaceutical representative system, and for the first time referred to the status of pharmaceutical representatives as "medical information experts."
also put forward the necessity of establishing an objective qualification evaluation system based on fair civil institutions while enriching the MR education and training system.
After two years of discussion and preparation, in 1996 the Government of Japan and the industry finally reached a consensus on the transition from the industry's own-directed system of educational training for pharmaceutical representatives to a system of identification of pharmaceutical representatives based on impartial third-party institutions.
1997, Japan formally implemented the MR recognition system, and its core institution, the MR Education Center, was established at this time.
held its first MR qualification exam in Japan in December of that year.
had been conducted five times as of December 1999, during which time a total of 50,000 people had taken the examination.
the number of people taking the exam had exceeded 100,000 by 2005.
more than 50,000 people passed the examination in 2004 to obtain a certificate of identification from a medical representative.
established the examination-centered identification system, Japan's medical representative system has not stopped the pace of reform.
2010, medical representatives decided to develop the so-called core curriculum (core Curriculum) system based on the addition of "imported courses" based on basic medical knowledge, and pharmaceutical representatives determined that the system had a simple examination to begin the transition to lifelong learning.
The current Japanese medicine representative identification system, consisting of import education, MR identification examination, continuing education three parts in 2012 based on the core curriculum of the new version of MR Test, with the introduction of education, examination, continuing education as the center of the three parts to form Japan's current medical representative system.
more than 150,000 people took the Japanese medical representative's test in 2015.
03 Reform? Revolution? Although constantly improving, but now, Japan's medical representative system has reached the point of reform.
MR Identification Center Director-General Yuzawa Yangping announced at a meeting held in Beijing in August this year that the Center decided to push forward the fundamental reform of the MR identification system, and to seek understanding from all walks of life, especially pharmaceutical companies.
the environment is very different now, even in December last year and now in a short period of time has changed a lot, " mr. Nearze said excitedly at the meeting.
"Syze's so-called change is also the reason for the reform of the medical representative system.
reforms are under way? In short, it is the crisis brought about by change.
In recent years, Japan's industry norms have also been tightened, medical institutions continue to implement restrictions on visits and visits by medical representatives, coupled with the development of the Japanese medical industry ICT (Information and Communication Technology), pharmaceutical representatives and medical practitioners contact substings are constantly compressed.
addition, the occasional "scandal" of receiving money, free entertainment, etc. has also led to the constant stigma of pharmaceutical representatives in Japanese society, and some Japanese media have even appeared on the "need for medical representatives" discussion.
is that the number of medical representatives taking the test has also been declining year by year since 2015.
these changes mean a crisis for Japan's medical representation system and pharmaceutical representatives, and reform is imminent.
a series of reforms from the inside out.
2016, the MR Recognition Center has established the Continuing Education Review Committee under the Education Research Council as an important part of enriching and strengthening "continuing education" in an attempt to further advance the transition of pharmaceutical representatives to lifelong learning.
the Continuing Education Review Committee has since introduced a number of reforms, even with previous changes to the "vision" of Japanese medical representatives.
2011 to welcome the 100th anniversary of the birth of medical representatives of the Pharmaceutical Representative Education and Research Committee will put forward the "as a member of the medical team, shouldering the medical mission" slogan as a modern Japanese medicine representative of the concept.
As soon as the Continuing Education Review Committee was established, it changed this rather loud idea to "to provide, collect and communicate medical information for patients with the goal of becoming a trusted partner of medical practitioners".
"fundamental reform" proposed an important part of the future reform of Japanese medicine representative, and this promulgation of the Outline is the first step in the reform.
The new Japanese pharmaceutical representatives decided that the system concept of the Outline of all zero, starting from what the pharmaceutical representatives, redefined the qualifications of Japanese pharmaceutical representatives, enterprises, pharmaceutical representatives, identification centers of their respective responsibilities, and for the first time in the form of clear text to confirm.
the Platform, the status and status of pharmaceutical representatives as "experts" in pharmaceutical information activities were re-emphasized, and for the first time since they were presented in writing in 1993.
expressed the hope that this is a reminder to Japan's pharmaceutical representatives continue to study their own expertise, on behalf of enterprises to convey the right drug information.
the Platform also removes the responsibility for "universalization" of drugs in the definition of pharmaceutical representatives, defining them as "contributions to the proper use of drugs and the promotion of drug therapies" in order to reduce the sense of increased sales resulting from "universalization".
previously issued documents describing only "the necessary knowledge, skills and ethics of medical representatives", and in this Outline, the knowledge, skills and ethics of what is clear.
said he hopes to win the trust of both patients and the general public in writing, outside the medical practitioners.
The Outline also clearly states that the previous work of the MR Identification Center focused mainly on the holding of qualification examinations and the delivery of certification certificates, the role of which will be transactional, and that in the future, the responsibilities for the evaluation and related systems of educational research and development of pharmaceutical companies will be increased, and specific reform measures are planned to be proposed within this year.
said the need for reform was entirely predictable and that without speeding up the process "changes more than we think".
reform of Japan's medical representation system has only just begun.